BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 17826393)

  • 1. Effect of growth hormone on cardiac contractility in patients with adult onset growth hormone deficiency.
    Cho GY; Jeong IK; Kim SH; Kim MK; Park WJ; Oh DJ; Yoo HJ
    Am J Cardiol; 2007 Sep; 100(6):1035-9. PubMed ID: 17826393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of growth hormone (GH) therapy on cardiac performance in patients with childhood onset GH deficiency.
    Minczykowski A; Gryczynska M; Ziemnicka K; Czepczynski R; Sowinski J; Wysocki H
    Growth Horm IGF Res; 2005 Apr; 15(2):156-64. PubMed ID: 15809020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of growth hormone therapy on ultrasound myocardial tissue characterization in patients with childhood onset GH deficiency.
    Minczykowski A; Gryczynska M; Ziemnicka K; Sowinski J; Wysocki H
    Int J Cardiol; 2005 May; 101(2):257-63. PubMed ID: 15882673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of GH replacement therapy on cardiac morphology and function, exercise capacity and serum lipids in elderly patients with GH deficiency.
    Elgzyri T; Castenfors J; Hägg E; Backman C; Thorén M; Bramnert M
    Clin Endocrinol (Oxf); 2004 Jul; 61(1):113-22. PubMed ID: 15212653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of growth hormone therapy in children after cardiac transplantation.
    Mital S; Andron A; Lamour JM; Hsu DT; Addonizio LJ; Softness B
    J Heart Lung Transplant; 2006 Jul; 25(7):772-7. PubMed ID: 16818119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac dimension and function in patients with childhood onset growth hormone deficiency, before and after growth hormone retreatment in adult age.
    Feinberg MS; Scheinowitz M; Laron Z
    Am Heart J; 2003 Mar; 145(3):549-53. PubMed ID: 12660681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of short-term therapy with recombinant human growth hormone (GH) on metabolic parameters and preclinical atherosclerotic markers in hypopituitary patients with growth hormone deficiency.
    Benedini S; Dalle Carbonare L; Albiger N; Scanarini M; Bilora F; Petrobelli F; Giannini S; Mantero F; Scaroni C
    Horm Metab Res; 2006 Jan; 38(1):16-21. PubMed ID: 16477535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac effects of growth hormone in adults with growth hormone deficiency: a meta-analysis.
    Maison P; Chanson P
    Circulation; 2003 Nov; 108(21):2648-52. PubMed ID: 14623813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac performance and mass in adults with hypopituitarism: effects of one year of growth hormone treatment.
    Valcavi R; Gaddi O; Zini M; Iavicoli M; Mellino U; Portioli I
    J Clin Endocrinol Metab; 1995 Feb; 80(2):659-66. PubMed ID: 7852533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired longitudinal myocardial velocities in patients with growth hormone deficiency improves after hormone replacement therapy.
    Ozdogru I; Tanriverdi F; Dogan A; Kaya MG; Tugrul Inanc M; Kalay N; Topsakal R; Unluhizarci K; Atmaca H; Kemal Eryol N; Kelestimur F
    J Am Soc Echocardiogr; 2007 Sep; 20(9):1093-9. PubMed ID: 17555934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of intrinsic myocardial contractility and cardiac fibrosis degree in acromegalic patients treated with somatostatin analogues: a prospective study.
    Bogazzi F; Di Bello V; Palagi C; Donne MG; Di Cori A; Gavioli S; Talini E; Cosci C; Sardella C; Brogioni S; Mariani M; Martino E
    Clin Endocrinol (Oxf); 2005 May; 62(5):590-6. PubMed ID: 15853830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of 12 months of growth hormone replacement therapy on cardiac autonomic tone in adults with growth hormone deficiency.
    Tanriverdi F; Eryol NK; Atmaca H; Unluhizarci K; Ozdogru I; Sarikaya I; Bayram F; Kelestimur F
    Clin Endocrinol (Oxf); 2005 Jun; 62(6):706-12. PubMed ID: 15943833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serum tumor marker levels during a 12-months growth hormone replacement therapy in patients with adult growth hormone deficiency].
    Hubina E; Kovács L; Szabolcs I; Rimanóczy E; Czirják S; Góth M
    Orv Hetil; 2002 Mar; 143(12):601-5. PubMed ID: 11963397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of five-year growth hormone replacement therapy on muscle strength in elderly hypopituitary patients.
    Götherström G; Bengtsson BA; Sunnerhagen KS; Johannsson G; Svensson J
    Clin Endocrinol (Oxf); 2005 Jan; 62(1):105-13. PubMed ID: 15638878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of the skin characteristics in patients with severe GH deficiency and the effects of 6 months of GH replacement therapy: a randomized placebo controlled study.
    Tanriverdi F; Borlu M; Atmaca H; Koc CA; Unluhizarci K; Utas S; Kelestimur F
    Clin Endocrinol (Oxf); 2006 Nov; 65(5):579-85. PubMed ID: 17054457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune system in adults with childhood-onset growth hormone deficiency: effect of growth hormone therapy.
    Lebl J; Sediva A; Snajderova M; Pruhova S; Rakosnikova V
    Endocr Regul; 2000 Dec; 34(4):169-73. PubMed ID: 11135489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumour surveillance imaging in patients with extrapituitary tumours receiving growth hormone replacement.
    Chung TT; Drake WM; Evanson J; Walker D; Plowman PN; Chew SL; Grossman AB; Besser GM; Monson JP
    Clin Endocrinol (Oxf); 2005 Sep; 63(3):274-9. PubMed ID: 16117814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early epirubicin-induced myocardial dysfunction revealed by serial tissue Doppler echocardiography: correlation with inflammatory and oxidative stress markers.
    Mercuro G; Cadeddu C; Piras A; Dessì M; Madeddu C; Deidda M; Serpe R; Massa E; Mantovani G
    Oncologist; 2007 Sep; 12(9):1124-33. PubMed ID: 17914082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone (GH) replacement therapy in GH deficient adults: predictors of one-year metabolic and clinical response.
    Svensson J; Finer N; Bouloux P; Bevan J; Jonsson B; Mattsson AF; Lundberg M; Harris PE; Koltowska-Häggström M; Monson JP;
    Growth Horm IGF Res; 2007 Feb; 17(1):67-76. PubMed ID: 17223598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
    Chihara K; Kato Y; Kohno H; Takano K; Tanaka T; Teramoto A; Shimatsu A
    Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.